Cargando…

Effect of Early Everolimus-Facilitated Reduction of Tacrolimus on Efficacy and Renal Function in De Novo Liver Transplant Recipients: 24-Month Results for the North American Subpopulation

BACKGROUND: A recent randomized phase III study of 719 de novo liver transplant recipients showed that early everolimus plus reduced-dose tacrolimus (EVR + rTAC) led to significantly better kidney function than standard TAC (TAC-C), without compromising efficacy. In that study, patients from North A...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chapman, William C., Brown, Robert S., Chavin, Kenneth D., Sudan, Debra, Koneru, Baburao, Junge, Guido, Dong, Gaohong, Patel, Dharmesh, Teperman, Lewis, Fung, John J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2017
Materias:	Original Clinical Science—Liver
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5265688/ https://www.ncbi.nlm.nih.gov/pubmed/28121741 http://dx.doi.org/10.1097/TP.0000000000001524

Ejemplares similares

Everolimus With Reduced Tacrolimus Improves Renal Function in De Novo Liver Transplant Recipients: A Randomized Controlled Trial
por: De Simone, P, et al.
Publicado: (2012)

Efficacy and Safety of Everolimus With Reduced Tacrolimus in Liver Transplant Recipients: 24-month Results From the Pooled Analysis of 2 Randomized Controlled Trials
por: Lee, Sung-Gyu, et al.
Publicado: (2020)

Everolimus Is Associated With Less Weight Gain Than Tacrolimus 2 Years After Liver Transplantation: Results of a Randomized Multicenter Study
por: Charlton, Michael, et al.
Publicado: (2017)

Long-term, Prolonged-release Tacrolimus-based Immunosuppression in De Novo Liver Transplant Recipients: 5-year Prospective Follow-up of Patients in the DIAMOND Study
por: Friman, Styrbjörn, et al.
Publicado: (2021)

Short- and Long-term Outcomes of De Novo Liver Transplant Patients Treated With Once-Daily Prolonged-Release Tacrolimus
por: Okumura, Yuichiro, et al.
Publicado: (2017)

Understanding the Impact of Pneumonia and Other Complications in Elderly Liver Transplant Recipients: An Analysis of NSQIP Transplant
por: Schnickel, Gabriel T., et al.
Publicado: (2021)

Sequential Cohort Analysis After Liver Transplantation Shows de Novo Extended Release Tacrolimus Is Safe, Efficacious, and Minimizes Renal Dysfunction
por: Lim, Tiong Yeng, et al.
Publicado: (2020)

Renal Protective Effect of Everolimus in Liver Transplantation: A Prospective Randomized Open-Label Trial
por: Kadry, Zakiyah, et al.
Publicado: (2021)

Response to the NCEPOD report: development of a care bundle for patients admitted with decompensated cirrhosis—the first 24 h
por: McPherson, Stuart, et al.
Publicado: (2016)

Pantoprazole Does not Affect Serum Trough Levels of Tacrolimus and Everolimus in Liver Transplant Recipients
por: Bremer, Sebastian C. B., et al.
Publicado: (2018)

Results of the TOP Study: Prospectively Randomized Multicenter Trial of an Ex Vivo Tacrolimus Rinse Before Transplantation in EDC Livers
por: Pratschke, Sebastian, et al.
Publicado: (2016)

Long-term Follow-up of a Randomized Trial of Tacrolimus or Cyclosporine A Microemulsion in Children Post Liver Transplantation
por: Lloyd, Carla, et al.
Publicado: (2021)

“Raising HOPE”: Improved Outcomes for HIV/HCV-coinfected Liver Transplant Recipients in the Direct-acting Antiviral Era
por: Cotter, Thomas G., et al.
Publicado: (2021)

Differences in Liver Graft Survival by Recipient Sex
por: De Simone, Alexia I., et al.
Publicado: (2020)

Selecting DCD Recipients Using Predictive Indices
por: Ganni, Saif, et al.
Publicado: (2023)

Tacrolimus-induced gingival hyperplasia and recovery from tacrolimus to everolimus switching
por: Oral, Alihan, et al.
Publicado: (2019)

Pharmacokinetics of Once‐Daily Extended‐Release Tacrolimus Tablets Versus Twice‐Daily Capsules in De Novo Liver Transplant
por: DuBay, Derek A., et al.
Publicado: (2019)

Efficacy and Safety of Low-Dose Cyclosporine with Everolimus and Steroids in de novo Heart Transplant Patients: A Multicentre, Randomized Trial
por: Zuckermann, Andreas, et al.
Publicado: (2011)

Characterization of Gut Microbiome in Liver Transplant Recipients With Nonalcoholic Steatohepatitis
por: Satapathy, Sanjaya K., et al.
Publicado: (2020)

An Unusual Cause of Acute Pancreatitis in a Liver Transplant Recipient
por: Nizamuddin, Imran, et al.
Publicado: (2021)

The Role of Arterial Stiffness in the Estimation of Cardiovascular Risk in Liver Transplant Recipients
por: Sastre, Lydia, et al.
Publicado: (2021)

Development of a Predictive Model for Hyperglycemia in Nondiabetic Recipients After Liver Transplantation
por: Zelada, Henry, et al.
Publicado: (2018)

Association of Perioperative Variables and the Acute Respiratory Distress Syndrome in Liver Transplant Recipients
por: Ripoll, Juan G., et al.
Publicado: (2019)

Poor Practitioner Adherence to Clinical Tobacco Use Guidelines in Liver Transplant Recipients
por: Harrington, Claire, et al.
Publicado: (2022)

Liver Transplantation in Recipients With Class III Obesity: Posttransplant Outcomes and Weight Gain
por: Soma, Daiki, et al.
Publicado: (2022)

Tough Nut to Crack: Transplant-acquired Food Allergy in an Adult Liver Recipient
por: Horwich, Brian H., et al.
Publicado: (2023)

Fever and Pancytopenia in a Liver Transplant Recipient: Going Against the Rules of Occam's Razor
por: Lum, Lionel Hon Wai, et al.
Publicado: (2017)

Invasive Candida Infections in Liver Transplant Recipients: Clinical Features and Risk Factors for Mortality
por: Bassetti, Matteo, et al.
Publicado: (2017)

Utility of Metabolomic Biomarkers to Identify Nonalcoholic Fatty Liver Disease in Liver Transplant Recipients
por: Mowry, Christopher J., et al.
Publicado: (2021)

Outcomes in Adult Liver Transplant Recipients Using Pediatric Deceased Donor Liver Grafts
por: Vargas, Paola A., et al.
Publicado: (2022)

Cognitive Impairment in Liver Transplant Recipients With a History of Cirrhosis: A Systematic Review
por: Siddiqui, Osama M., et al.
Publicado: (2023)

Long-term Outcome of Endoscopic and Percutaneous Transhepatic Approaches for Biliary Complications in Liver Transplant Recipients
por: Rönning, Jesper, et al.
Publicado: (2019)

Impact of Recipient Age in Combined Liver-Kidney Transplantation: Caution Is Needed for Patients ≥70 Years
por: Ekser, Burcin, et al.
Publicado: (2020)

Insights Into the Experience of Liver Transplant Recipients With Alcoholic Liver Disease: A Descriptive Qualitative Study
por: Hochheimer, Martin, et al.
Publicado: (2019)

Protein-losing Enteropathy Due to Inferior Vena Cava Stenosis in a Liver Transplant Recipient
por: Anugwom, Chimaobi M., et al.
Publicado: (2021)

Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipients with Hepatocellular Carcinoma
por: Sapisochin, Gonzalo, et al.
Publicado: (2022)

Efficacy and safety of tacrolimus in de novo pediatric transplant recipients randomized to receive immediate‐ or prolonged‐release tacrolimus
por: Vondrak, Karel, et al.
Publicado: (2019)

A Novel Surgical Technique to Assure Donor and Recipient Safety: Pyloric to Segment 4 Arterial Reconstruction
por: Fraile, Andres, et al.
Publicado: (2020)

Telehealth-delivered, Cardioprotective Diet and Exercise Program for Liver Transplant Recipients: A Randomized Feasibility Study
por: Hickman, Ingrid J., et al.
Publicado: (2021)

A Donor Age-Based and Graft Volume–Based Analysis for Living Donor Liver Transplantation in Elderly Recipients
por: Imamura, Hajime, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_2dup8nb4d312uuh29lffl9ubfu